An Open Labelled Randomized Controlled Trial to Evaluate the Efficacy of Dwipanchmooladi Tailam Matra Basti, Singhnad Guggulu, Baluka Swedana in the Management of Aamvata w.s.r. to Rheumatoid Arthritis - A Study Protocol
Journal of Ayurveda and Integrated Medical Sciences · 21.07.2026 · 11 (6) · 192-198
DOI: 10.21760/jaims.11.6.29 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Ayurveda and Integrated Medical Sciences, online erschienen am 21.07.2026. Verfasst von Pooja Rani und 1 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Aamavata is a disorder described in Ayurveda resulting from the interaction of Ama and vitiated Vata. It develops due to factors such as Viruddha Ahara, Mandagni, sedentary habits, and improper lifestyle practices, leading to the formation of Ama. This Ama circulates with aggravated doshas and localizes in Shleshma Sthana, where Kha-Vaigunya exists, leads to Daurbalya, Hridyagaurava, Stabdhata. Clinically, Aamavata resembles Rheumatoid Arthritis, a chronic systemic inflammatory disease affecting small and large diarthrodial joints. As Vata predominance is central in its pathogenesis, Basti Chikitsa is considered the best treatment. Acharya Chakradatta has indicated Basti in Aamavata management. Dwipanchmooladi Taila, possessing Tikta, Kashaya, Madhura rasa, Laghu, Ushna guna, and Amapachana properties, is selected as Matra Basti in this study.
Aim
Evaluation of impact of Dwipanchmooladi Tailam Matra Basti on the level of Anti-CCP, and secondarily on the level of R.A Factor, ESR and CRP in the patients of Aamvata. (R.A)
Objectives
To assess the effect of Dwipanchmooladi Tailam Matra Basti in the reduction of Anti-CCP levels in the patients of Aamvata. (R.A). Methodology: 60 patients of Aamvata will be selected on the basis of selection criteria. All patients will be divided into two groups. Each group having 30 patients. In group A patients Singhnaad Guggulu and Baluka Swedana will be given for 24 days and in group B patients Dwipanchmooladi Tailam Matra Basti will be given for 24 days (Basti will be given for 8 days, then 8 days gap interval will be kept then next 8 days Basti will be given (2 cycles of Basti each 8 days.) along with Singhnaad Guggulu and Baluka Swedana. Observations will be done on the basis of before and after subjective and objective parameters and clinical investigations.
Zitieren
APA
Rani, P., & Mehta, A. (2026). An Open Labelled Randomized Controlled Trial to Evaluate the Efficacy of Dwipanchmooladi Tailam Matra Basti, Singhnad Guggulu, Baluka Swedana in the Management of Aamvata w.s.r. to Rheumatoid Arthritis - A Study Protocol. Journal of Ayurveda and Integrated Medical Sciences, 11(6), 192-198. https://doi.org/10.21760/jaims.11.6.29
Vancouver
Rani P, Mehta A. An Open Labelled Randomized Controlled Trial to Evaluate the Efficacy of Dwipanchmooladi Tailam Matra Basti, Singhnad Guggulu, Baluka Swedana in the Management of Aamvata w.s.r. to Rheumatoid Arthritis - A Study Protocol. Journal of Ayurveda and Integrated Medical Sciences. 2026;11(6):192-198. doi:10.21760/jaims.11.6.29
BibTeX
@article{Rani2026,
author = {Rani, Pooja and Mehta, Ashish},
title = {An Open Labelled Randomized Controlled Trial to Evaluate the Efficacy of Dwipanchmooladi Tailam Matra Basti, Singhnad Guggulu, Baluka Swedana in the Management of Aamvata w.s.r. to Rheumatoid Arthritis - A Study Protocol},
journal = {Journal of Ayurveda and Integrated Medical Sciences},
year = {2026},
volume = {11},
number = {6},
pages = {192--198},
doi = {10.21760/jaims.11.6.29}
}
EUVIMED